210 related articles for article (PubMed ID: 12919154)
1. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans.
Giordano R; Grottoli S; Brossa P; Pellegrino M; Destefanis S; Lanfranco F; Gianotti L; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2003 Sep; 59(3):314-20. PubMed ID: 12919154
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Gianotti L; Broglio F; Benso A; Deghenghi R; Camanni F; Ghigo E
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
4. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
[TBL] [Abstract][Full Text] [Related]
5. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
Grottoli S; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; DeStefanis S; Camanni F; Ghigo E; Arvat E
J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
[TBL] [Abstract][Full Text] [Related]
6. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
Hohnloser J; Von Werder K; Müller OA
Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
[TBL] [Abstract][Full Text] [Related]
7. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
[TBL] [Abstract][Full Text] [Related]
8. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects.
Inder WJ; Livesey JH; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1996 Jan; 44(1):7-13. PubMed ID: 8706296
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
Arvat E; Maccagno B; Ramunni J; Di Vito L; Giordano R; Gianotti L; Broglio F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1999 Aug; 84(8):2611-5. PubMed ID: 10443648
[TBL] [Abstract][Full Text] [Related]
10. Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease.
Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
Pituitary; 1999 Nov; 2(3):197-204. PubMed ID: 11081154
[TBL] [Abstract][Full Text] [Related]
11. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
Coiro V; Volpi R; Casti A; Maffei ML; Stella A; Volta E; Chiodera P
Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
[TBL] [Abstract][Full Text] [Related]
12. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[TBL] [Abstract][Full Text] [Related]
13. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans.
Arvat E; Maccagno B; Ramunni J; Maccario M; Giordano R; Broglio F; Camanni F; Ghigo E
Eur J Endocrinol; 2000 Jul; 143(1):99-104. PubMed ID: 10870037
[TBL] [Abstract][Full Text] [Related]
14. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus.
Kinsley BT; Simonson DC
J Clin Endocrinol Metab; 1996 Feb; 81(2):684-91. PubMed ID: 8636289
[TBL] [Abstract][Full Text] [Related]
16. Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients.
Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S136-7. PubMed ID: 10997633
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[TBL] [Abstract][Full Text] [Related]
18. Adrenocorticotrophic hormone, cortisol and catecholamine concentrations during insulin hypoglycaemia in dogs anaesthetized with thiopentone.
Toso CF; Rodríguez RR; Renauld AR; Márquez AG; Linares LM
Can J Anaesth; 1993 Nov; 40(11):1084-91. PubMed ID: 8269572
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
Pfeifer M; Kanc K; Verhovec R; Kocijancic A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
[TBL] [Abstract][Full Text] [Related]
20. The use of the hypoglycaemic clamp in the assessment of pituitary function.
Semakula C; Damberg G; Kendall D; Seaquist ER
Clin Endocrinol (Oxf); 1999 Dec; 51(6):709-14. PubMed ID: 10619975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]